Stay updated on RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.

Latest updates to the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page
- Check3 days agoChange DetectedRecruitment status changed to 'No longer looking for participants' and the study record version was updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

- Check10 days agoChange DetectedA new revision entry v3.5.5 was added to the study history, replacing the previous v3.5.4 and indicating an update to the page's version history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe Record History now shows Revision: v3.5.4 as the current version, replacing Revision: v3.5.3 in the history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s displayed revision/version string was updated from v3.5.2 to v3.5.3, reflecting a site/UI software update rather than a change to the study record details.SummaryDifference0.1%

- Check60 days agoChange DetectedSponsor name updated to 'Replimune, Inc.' and a new revision 'Revision: v3.5.2' was added; the previous entries 'Replimune Inc.' and 'Revision: v3.5.0' were removed.SummaryDifference0.3%

- Check89 days agoChange DetectedA new revision v3.5.0 is added to the Study Record Versions, and the previous revision v3.4.3 is removed.SummaryDifference0.1%

Stay in the know with updates to RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.